Previous study demonstrated that COG1410, a triggering receptor expressed on myeloid cells 2 (TREM2) activator, improves post-TBI cognitive impairment through activation of the Akt/CREB/BDNF pathway and inhibition of caspase-3-dependent neuronal apoptosis [38]. Here, CASP3 is linked to Cognitive impairment.